Ranking Year:
# | Company Name | Region | Tech Topics | Total |
---|
1 | ![]() STARTUP | Viscosity,Health care,Pharmacy and Therapeutics, ...[+2] | Avg patent value: 9.08 M | |
2 | ![]() UNICORN | Medicine,Medical equipment,Health care, ...[+2] | Avg patent value: 8.43 M | |
3 | ![]() STARTUP | Immunotherapy,Health care,Clinical trial, ...[+2] | Avg patent value: 8.02 M | |
4 | ![]() STARTUP | Biotechnology,Drug development,Biopharmaceutical, ...[+2] | Avg patent value: 6.24 M | |
5 | ![]() STARTUP | Clinical trial,Medicine,Health care, ...[+2] | Avg patent value: 4.30 M | |
6 | ![]() STARTUP | Cancer vaccine,Pharmacy and Therapeutics,Biotechnology, ...[+2] | Avg patent value: 3.15 M | |
7 | ![]() STARTUP | Rhône-Alpes, France | Monoclonal antibody,Health care,Pharmacy and Therapeutics, ...[+2] | Avg patent value: 2.88 M |
8 | ![]() STARTUP | Medicine,Pharmacy and Therapeutics,Cell therapy, ...[+2] | Avg patent value: 2.83 M | |
9 | ![]() STARTUP | E-commerce | Avg patent value: 2.48 M | |
10 | ![]() STARTUP | Herefordshire, United Kingdom | Biomolecule,Product design,Industrial engineering, ...[+2] | Avg patent value: 2.39 M |
11 | ![]() STARTUP | Monoclonal antibody,Medicine,Omalizumab, ...[+2] | Avg patent value: 1.85 M | |
12 | ![]() STARTUP | Pharmacy and Therapeutics,Monoclonal antibody,Antibody, ...[+2] | Avg patent value: 1.77 M | |
13 | ![]() STARTUP | Health care,Pharmacy and Therapeutics,Oncology drugs, ...[+2] | Avg patent value: 1.50 M | |
14 | ![]() STARTUP | Dormancy,Primary tumor | Avg patent value: 1.33 M | |
15 | ![]() STARTUP | Cell sorting,Biology,Systems design, ...[+2] | Avg patent value: 1.26 M | |
16 | ![]() UNICORN | Biosimilar,Medicine,Antibody, ...[+2] | Avg patent value: 1.14 M | |
17 | ![]() STARTUP | Abruzzi, Italy | Monoclonal antibody,Health care | Avg patent value: 1.02 M |
18 | ![]() STARTUP | Southern Finland, Finland | Cancer immunotherapy,Medicine,Health care, ...[+2] | Avg patent value: 960,000 |
19 | ![]() STARTUP | Biopharmaceutical | Avg patent value: 940,000 | |
20 | ![]() STARTUP | Medicine,Health care,Cancer, ...[+2] | Avg patent value: 720,000 | |
21 | ![]() STARTUP | Antigen-presenting cell,Tumor microenvironment,Medicine, ...[+2] | Avg patent value: 698,571 | |
22 | ![]() STARTUP | Antibody,Coronavirus disease 2019 (COVID-19),Drug, ...[+2] | Avg patent value: 542,500 | |
23 | ![]() STARTUP | Cancer,Oncology,Chemical engineering | Avg patent value: 540,000 | |
24 | ![]() STARTUP | Tokyo, Japan | Antibody,Medicine,Molecule, ...[+2] | Avg patent value: 497,400 |
25 | ![]() STARTUP | Alberta, Canada | Health care,Biopharmaceutical,Specific immunity, ...[+2] | Avg patent value: 471,333 |
26 | ![]() STARTUP | B cell,Immunotherapy,Biotechnology, ...[+2] | Avg patent value: 435,294 | |
27 | ![]() STARTUP | Cytokine,Prodrug,Cytokine Therapy, ...[+1] | Avg patent value: 430,000 | |
28 | ![]() STARTUP | Emilia-Romagna, Italy | Health care,Cell,Drug, ...[+2] | Avg patent value: 280,000 |
29 | ![]() STARTUP | Liquid biopsy,Health care | Avg patent value: 230,000 | |
30 | ![]() STARTUP | Biopharmaceutical,Medicine,Health care, ...[+2] | Avg patent value: 220,000 | |
31 | ![]() STARTUP | Genome editing,CRISPR,Genome, ...[+2] | Avg patent value: 180,000 | |
32 | ![]() STARTUP | Utrecht, Netherlands | Macromolecule,Biology,Plasmid, ...[+2] | Avg patent value: 173,325 |
33 | ![]() STARTUP | Medicine,Health care,Diagnostic Reagent, ...[+2] | Avg patent value: 128,571 | |
34 | ![]() STARTUP | Antibody | Avg patent value: 100,000 | |
35 | ![]() STARTUP | Angiogenesis,Biology,Pharmacy and Therapeutics, ...[+2] | Avg patent value: 100,000 | |
36 | ![]() STARTUP | Peanut allergy,Allergy drugs | Avg patent value: 99,000 | |
37 | ![]() STARTUP | Medicine,Pharmacy and Therapeutics,Autoimmune disease, ...[+2] | Avg patent value: 90,000 | |
38 | ![]() STARTUP | Health care,Cell,Hematological neoplasm, ...[+2] | Avg patent value: 76,850 | |
39 | ![]() STARTUP | Herefordshire, United Kingdom | Chronic stress,Black belt,Therapeutic approach, ...[+1] | Avg patent value: 75,057 |
40 | ![]() STARTUP | Victoria, Australia | Phosphatase,Kinase,Enzyme, ...[+2] | Avg patent value: 66,000 |
41 | ![]() STARTUP | Drug,Antibody,Medicine, ...[+1] | Avg patent value: 64,000 | |
42 | ![]() STARTUP | Gene,Biology,Health care, ...[+2] | Avg patent value: 63,000 | |
43 | ![]() STARTUP | Pharmacy and Therapeutics,Biomedicine,Biotechnology, ...[+2] | Avg patent value: 62,288 | |
44 | ![]() STARTUP | Niedersachsen, Germany | Diagnostic Reagent,Medicine,Protein engineering, ...[+2] | Avg patent value: 58,000 |
45 | ![]() STARTUP | Jerusalem, Israel | Nectin,Biology,Antibody, ...[+2] | Avg patent value: 49,000 |
46 | ![]() STARTUP | Oncology,Herb,Botanical drug, ...[+2] | Avg patent value: 48,200 | |
47 | ![]() STARTUP | Herb,Botanical drug,Biology, ...[+2] | Avg patent value: 47,085 | |
48 | ![]() STARTUP | Pharmacy and Therapeutics,Health care,Biotechnology, ...[+2] | Avg patent value: 45,000 | |
49 | ![]() STARTUP | Medicine | Avg patent value: 39,200 | |
50 | ![]() STARTUP | HaZafon, Israel | Medicine,Breakthrough therapy,Cancer immunotherapy, ...[+2] | Avg patent value: 39,000 |